Data / Form D filings / Omthera Pharmaceuticals, Inc.
Omthera Pharmaceuticals, Inc.: Form D filings
Omthera Pharmaceuticals, Inc., a pharmaceuticals company in New Jersey, NJ, filed 4 Form D notices with the SEC between 2009 and 2013. The latest, on February 28, 2013, reports $17.6 million sold of an offering with no set size to 13 investors.
Find out what Omthera Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 707 STATE ROAD, New Jersey, NJ, 08540
- Phone
- (908) 741-4399
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1477598
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 28, 2013 | New notice | Indefinite | $17,600,000 | Indefinite | 13 | Feb 15, 2013 | sec.gov |
| Jan 6, 2012 | Amendment | $49,009,465 | $39,009,465 | $10,000,000 | 10 | Feb 28, 2011 | sec.gov |
| Mar 15, 2011 | New notice | $38,659,480 | $33,909,471 | $4,750,009 | 7 | Feb 28, 2011 | sec.gov |
| Nov 27, 2009 | New notice | Indefinite | $2,158,333 | Indefinite | 4 | Nov 13, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Mott | Director | |
| Graziano Seghezzi | Director | |
| Bernardus Machielse | Executive Officer | |
| George Horner | Director | |
| Michael Davidson | Executive Officer | |
| Gerald Wisler | Executive Officer, Director | |
| Christian Schade | Executive Officer |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Feb 25, 2013 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Omthera Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.